The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transforming Growth Factor Beta 1 Market Research Report 2025
Synopsis
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
The global Transforming Growth Factor Beta 1 market was valued at US$ 1458.2 million in 2023 and is anticipated to reach US$ 3072.5 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
Report Scope
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transforming Growth Factor Beta 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
The global Transforming Growth Factor Beta 1 market was valued at US$ 1458.2 million in 2023 and is anticipated to reach US$ 3072.5 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
Report Scope
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transforming Growth Factor Beta 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transforming Growth Factor Beta 1 Market Overview
1.1 Product Overview and Scope of Transforming Growth Factor Beta 1
1.2 Transforming Growth Factor Beta 1 Segment by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Value Comparison by Type (2024-2030)
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Transforming Growth Factor Beta 1 Segment by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Value by Application: (2024-2030)
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
1.4.1 Global Transforming Growth Factor Beta 1 Revenue 2019-2030
1.4.2 Global Transforming Growth Factor Beta 1 Sales 2019-2030
1.4.3 Global Transforming Growth Factor Beta 1 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transforming Growth Factor Beta 1 Market Competition by Manufacturers
2.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturers (2019-2024)
2.4 Global Transforming Growth Factor Beta 1 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transforming Growth Factor Beta 1, Product Type & Application
2.7 Transforming Growth Factor Beta 1 Market Competitive Situation and Trends
2.7.1 Transforming Growth Factor Beta 1 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transforming Growth Factor Beta 1 Players Market Share by Revenue
2.7.3 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transforming Growth Factor Beta 1 Retrospective Market Scenario by Region
3.1 Global Transforming Growth Factor Beta 1 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transforming Growth Factor Beta 1 Global Transforming Growth Factor Beta 1 Sales by Region: 2019-2030
3.2.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2019-2024
3.2.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2025-2030
3.3 Global Transforming Growth Factor Beta 1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2019-2030
3.3.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2019-2024
3.3.2 Global Transforming Growth Factor Beta 1 Revenue by Region: 2025-2030
3.4 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.4.1 North America Transforming Growth Factor Beta 1 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transforming Growth Factor Beta 1 Sales by Country (2019-2030)
3.4.3 North America Transforming Growth Factor Beta 1 Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.5.1 Europe Transforming Growth Factor Beta 1 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2019-2030)
3.5.3 Europe Transforming Growth Factor Beta 1 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.6.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2019-2030)
3.6.3 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.7.1 Latin America Transforming Growth Factor Beta 1 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transforming Growth Factor Beta 1 Sales by Country (2019-2030)
3.7.3 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transforming Growth Factor Beta 1 Sales by Type (2019-2030)
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2019-2024)
4.1.2 Global Transforming Growth Factor Beta 1 Sales by Type (2025-2030)
4.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2030)
4.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2019-2030)
4.2.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2019-2024)
4.2.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2025-2030)
4.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2019-2030)
4.3 Global Transforming Growth Factor Beta 1 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transforming Growth Factor Beta 1 Sales by Application (2019-2030)
5.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2019-2024)
5.1.2 Global Transforming Growth Factor Beta 1 Sales by Application (2025-2030)
5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2030)
5.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2019-2030)
5.2.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2019-2024)
5.2.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2025-2030)
5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2019-2030)
5.3 Global Transforming Growth Factor Beta 1 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Shionogi Ltd
6.2.1 Shionogi Ltd Corporation Information
6.2.2 Shionogi Ltd Description and Business Overview
6.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
6.2.5 Shionogi Ltd Recent Developments/Updates
6.3 Acceleron Pharma Inc
6.3.1 Acceleron Pharma Inc Corporation Information
6.3.2 Acceleron Pharma Inc Description and Business Overview
6.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
6.3.5 Acceleron Pharma Inc Recent Developments/Updates
6.4 Genzyme Corp
6.4.1 Genzyme Corp Corporation Information
6.4.2 Genzyme Corp Description and Business Overview
6.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
6.4.5 Genzyme Corp Recent Developments/Updates
6.5 Isarna Therapeutics GmbH
6.5.1 Isarna Therapeutics GmbH Corporation Information
6.5.2 Isarna Therapeutics GmbH Description and Business Overview
6.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
6.5.5 Isarna Therapeutics GmbH Recent Developments/Updates
6.6 Scholar Rock
6.6.1 Scholar Rock Corporation Information
6.6.2 Scholar Rock Description and Business Overview
6.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
6.6.5 Scholar Rock Recent Developments/Updates
6.7 Sirnaomics Inc
6.6.1 Sirnaomics Inc Corporation Information
6.6.2 Sirnaomics Inc Description and Business Overview
6.6.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.7.5 Sirnaomics Inc Recent Developments/Updates
6.8 Eli Lilly and Co
6.8.1 Eli Lilly and Co Corporation Information
6.8.2 Eli Lilly and Co Description and Business Overview
6.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
6.8.5 Eli Lilly and Co Recent Developments/Updates
6.9 Formation Biologics Inc
6.9.1 Formation Biologics Inc Corporation Information
6.9.2 Formation Biologics Inc Description and Business Overview
6.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.9.5 Formation Biologics Inc Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transforming Growth Factor Beta 1 Industry Chain Analysis
7.2 Transforming Growth Factor Beta 1 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transforming Growth Factor Beta 1 Production Mode & Process
7.4 Transforming Growth Factor Beta 1 Sales and Marketing
7.4.1 Transforming Growth Factor Beta 1 Sales Channels
7.4.2 Transforming Growth Factor Beta 1 Distributors
7.5 Transforming Growth Factor Beta 1 Customers
8 Transforming Growth Factor Beta 1 Market Dynamics
8.1 Transforming Growth Factor Beta 1 Industry Trends
8.2 Transforming Growth Factor Beta 1 Market Drivers
8.3 Transforming Growth Factor Beta 1 Market Challenges
8.4 Transforming Growth Factor Beta 1 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
